Table 1 |
||||
|
Demographic and tumor characteristics of invasive and in situ female breast cancer cases (Surveillance, Epidemiology, and End Results-13) |
||||
| Invasive |
||||
| Asian/Pacific Islander |
Hispanic |
African-American |
Non-Hispanic White |
|
| n = 15,933 (6.5) |
n = 15,355 (6.3) |
n = 19,105 (7.8) |
n = 193,513 (79.3) |
|
|
|
||||
| Demographics |
||||
| Diagnosis year |
||||
| 1992 |
854 (5.4) |
920 (6.0) |
1,237 (6.5) |
13,822 (7.1) |
| 1993 |
851 (5.3) |
869 (5.7) |
1,231 (6.4) |
13,732 (7.1) |
| 1994 |
870 (5.5) |
958 (6.2) |
1,299 (6.8) |
14,003 (7.2) |
| 1995 |
984 (6.2) |
995 (6.5) |
1,356 (7.1) |
14,333 (7.4) |
| 1996 |
1,045 (6.6) |
1,095 (7.1) |
1,392 (7.3) |
14,402 (7.4) |
| 1997 |
1,253 (7.9) |
1,067 (6.9) |
1,453 (7.6) |
15,289 (7.9) |
| 1998 |
1,292 (8.1) |
1,212 (7.9) |
1,483 (7.8) |
15,807 (8.2) |
| 1999 |
1,373 (8.6) |
1,264 (8.2) |
1,550 (8.1) |
16,048 (8.3) |
| 2000 |
1,352 (8.5) |
1,350 (8.8) |
1,506 (7.9) |
15,608 (8.1) |
| 2001 |
1,491 (9.4) |
1,327 (8.6) |
1,526 (8.0) |
16,033 (8.3) |
| 2002 |
1,558 (9.8) |
1,433 (9.3) |
1,683 (8.8) |
15,697 (8.1) |
| Tumor characteristics |
||||
| Hormone receptor status |
||||
| ER+/PR+ |
8,242 (51.8) |
6,619 (43.1) |
6,941 (36.3) |
101,364 (52.4) |
| ER+/PR- |
1,707 (10.7) |
1,558 (10.1) |
1,921 (10.1) |
21,653 (11.1) |
| ER-/PR+ |
324 (2.0) |
250 (1.6) |
374 (2.0) |
3,022 (1.6) |
| ER-/PR- |
2,504 (15.7) |
2,417 (15.7) |
4,243 (22.2) |
24,355 (12.6) |
| Other/unknown |
3,156 (19.8) |
4,511 (29.4) |
5,626 (29.4) |
43,119 (22.3) |
| Histology |
||||
| IDC |
11,780 (73.9) |
10,204 (66.5) |
12,824 (67.1) |
128,393 (66.3) |
| ILC |
748 (4.7) |
1,121 (7.3) |
1,190 (6.2) |
18,663 (9.7) |
| IDLC |
843 (5.3) |
1,152 (7.5) |
1,179 (6.2) |
14,963 (7.7) |
| Other/unknown |
2,562 (16.1) |
2,878 (18.7) |
3,912 (20.5) |
31,494 (16.3) |
| Size |
||||
| <2 cm |
8,669 (54.4) |
7,077 (46.1) |
7,904 (41.4) |
108,527 (56.1) |
| ≥ 2 cm |
6,076 (38.1) |
6,674 (43.5) |
8,711 (45.6) |
66,515 (34.4) |
| Unknown |
1,188 (7.5) |
1,604 (10.4) |
2,490 (13.0) |
18,471 (9.5) |
| In situ |
||||
| Asian/Pacific Islander |
Hispanic |
African-American |
Non-Hispanic White |
|
| n = 4,025 (8.4) |
n = 2,807 (5.9) |
n = 4,072 (8.5) |
n = 36,908 (77.1) |
|
| Demographics |
||||
| Diagnosis year |
||||
| 1992 |
115 (2.9) |
110 (3.9) |
177 (4.3) |
1,942 (5.3) |
| 1993 |
163 (4.0) |
117 (4.2) |
181(4.4) |
1,932 (5.2) |
| 1994 |
173 (4.3) |
138 (4.9) |
212 (5.2) |
2,043 (5.5) |
| 1995 |
214 (5.3) |
152 (5.4) |
259 (6.4) |
2,313 (6.3) |
| 1996 |
219 (5.4) |
160 (5.7) |
238 (5.8) |
2,411 (6.5) |
| 1997 |
245 (6.1) |
199 (7.1) |
300 (7.4) |
2,717 (7.4) |
| 1998 |
292 (7.3) |
237 (8.4) |
335 (8.2) |
3,182 (8.6) |
| 1999 |
381 (9.5) |
238 (8.5) |
350 (8.6) |
3,306 (9.0) |
| 2000 |
358 (8.9) |
257 (9.2) |
383 (9.4) |
3,344 (9.1) |
| 2001 |
447 (11.1) |
279 (9.9) |
412 (10.1) |
3,496 (9.5) |
| 2002 |
527 (13.1) |
287 (10.2) |
375 (9.3) |
3,497 (9.5) |
| 2003 |
451 (11.2) |
309 (11.0) |
413 (10.1) |
3,326 (9.0) |
| 2004 |
440 (10.9) |
324 (11.5) |
437 (10.7) |
3,399 (9.2) |
|
|
||||
|
Values in parentheses are percentages. ER, estrogen receptor; IDC, invasive ductal carcinoma; IDLC, invasive ducto-lobular carcinoma; ILC, invasive lobular carcinoma; PR, progesterone receptor. |
||||
|
Hausauer et al. Breast Cancer Research 2007 9:R90 doi:10.1186/bcr1839 |
||||
